These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30122951)

  • 1. Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
    Hua J; Shi S; Liang D; Liang C; Meng Q; Zhang B; Ni Q; Xu J; Yu X
    Onco Targets Ther; 2018; 11():4591-4608. PubMed ID: 30122951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for second-line chemotherapy in advanced gastric cancer?
    Wesolowski R; Lee C; Kim R
    Lancet Oncol; 2009 Sep; 10(9):903-12. PubMed ID: 19717092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis.
    da Rocha Lino A; Abrahão CM; Brandão RM; Gomes JR; Ferrian AM; Machado MC; Buzaid AC; Maluf FC; Peixoto RD
    J Gastrointest Oncol; 2015 Oct; 6(5):511-5. PubMed ID: 26487945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy versus best supportive care for extensive small cell lung cancer.
    Pelayo Alvarez M; Westeel V; Cortés-Jofré M; Bonfill Cosp X
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD001990. PubMed ID: 24282143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic neoplasm in 2011: an update.
    Saif MW
    JOP; 2011 Jul; 12(4):316-21. PubMed ID: 21737886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung.
    Goss GD; Spaans JN
    Oncologist; 2016 Feb; 21(2):205-13. PubMed ID: 26768483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
    Giuliano M; Schettini F; Rognoni C; Milani M; Jerusalem G; Bachelot T; De Laurentiis M; Thomas G; De Placido P; Arpino G; De Placido S; Cristofanilli M; Giordano A; Puglisi F; Pistilli B; Prat A; Del Mastro L; Venturini S; Generali D
    Lancet Oncol; 2019 Oct; 20(10):1360-1369. PubMed ID: 31494037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
    Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer.
    Gränsmark E; Bågenholm Bylin N; Blomstrand H; Fredrikson M; Åvall-Lundqvist E; Elander NO
    Front Oncol; 2020; 10():1176. PubMed ID: 32850339
    [No Abstract]   [Full Text] [Related]  

  • 12. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.
    Janmaat VT; Steyerberg EW; van der Gaast A; Mathijssen RH; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD004063. PubMed ID: 29182797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination versus mono-therapy as salvage treatment for advanced biliary tract cancer: A comprehensive meta-analysis of published data.
    Ying J; Chen J
    Crit Rev Oncol Hematol; 2019 Jul; 139():134-142. PubMed ID: 30979533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
    Stevens R; Macbeth F; Toy E; Coles B; Lester JF
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD002143. PubMed ID: 25586198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
    Shih T; Lindley C
    Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan.
    Furuse J
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31382681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
    Skoetz N; Will A; Monsef I; Brillant C; Engert A; von Tresckow B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD007941. PubMed ID: 28541603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?
    Aprile G; Negri FV; Giuliani F; De Carlo E; Melisi D; Simionato F; Silvestris N; Brunetti O; Leone F; Marino D; Santini D; Dell'Aquila E; Zeppola T; Puzzoni M; Scartozzi M
    Crit Rev Oncol Hematol; 2017 Jul; 115():1-12. PubMed ID: 28602164
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.